RHONDA MCPHERSON: Open Payments
NPI 1194263715 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 16 payments from 8 companies in 2025. Trend: 2023 $246 · 2024 $300 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $151 |
| Indivior Inc. | 4 | $109 |
| Braeburn Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Alkermes, Inc. | 1 | $23 |
| Sage Therapeutics, LLC | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: INGREZZA, SUBLOCADE, BRIXADI, VIVITROL, ZURZUVAE, Qelbree, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
